Gain-of-Function Mutations of c- <i>kit</i> in Human Gastrointestinal Stromal Tumors

Seiichi Hirota(Osaka Rosai Hospital), Koji Isozaki(Osaka Rosai Hospital), Y Moriyama(Osaka Rosai Hospital), Koji Hashimoto(Osaka Rosai Hospital), Toshirou Nishida(Osaka Rosai Hospital), Shingo Ishiguro(Osaka Rosai Hospital), Kiyoshi Kawano(Osaka Rosai Hospital), Masato Hanada(Osaka Rosai Hospital), A Kurata(Osaka Rosai Hospital), Masashi Takeda(Osaka Rosai Hospital), Ghulam Muhammad Tunio(Osaka Rosai Hospital), Yūji Matsuzawa(Osaka Rosai Hospital), Yuzuru Kanakura(Osaka Rosai Hospital), Yasuhisa Shinomura(Osaka Rosai Hospital), Yukihiko Kitamura(Osaka Rosai Hospital)
Science
January 23, 1998
Cited by 4,475

Abstract

Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors in the human digestive tract, but their molecular etiology and cellular origin are unknown. Sequencing of c-kit complementary DNA, which encodes a proto-oncogenic receptor tyrosine kinase (KIT), from five GISTs revealed mutations in the region between the transmembrane and tyrosine kinase domains. All of the corresponding mutant KIT proteins were constitutively activated without the KIT ligand, stem cell factor (SCF). Stable transfection of the mutant c-kit complementary DNAs induced malignant transformation of Ba/F3 murine lymphoid cells, suggesting that the mutations contribute to tumor development. GISTs may originate from the interstitial cells of Cajal (ICCs) because the development of ICCs is dependent on the SCF-KIT interaction and because, like GISTs, these cells express both KIT and CD34.


Related Papers

No related papers found

Powered by citation graph analysis